Home » Authors » Aaron Lorenzo

Aaron Lorenzo

Articles

ARTICLES

House Committee Probes EPO Use, Costs In Dialysis Setting

Dec. 7, 2006

By Aaron Lorenzo

House Committee Probes EPO Use, Costs In Dialysis Setting

Dec. 7, 2006

By Aaron Lorenzo

Senate Expected To Approve Von Eschenbach As FDA Head

Dec. 6, 2006

By Aaron Lorenzo

Senate Expected To Approve Von Eschenbach As FDA Head

Dec. 6, 2006

By Aaron Lorenzo

House Committee To Take Up Uncertainties Around EPO Use

Dec. 4, 2006

By Aaron Lorenzo

House Committee To Take Up Uncertainties Around EPO Use

Dec. 4, 2006

By Aaron Lorenzo

Device identification concerns get hearing

Dec. 1, 2006

By Aaron Lorenzo

Cancer Company Xanthus Adding $25M Via Series B

Dec. 1, 2006

By Aaron Lorenzo

Cancer Company Xanthus Adding $25M Via Series B

Dec. 1, 2006

By Aaron Lorenzo

Hepatitis B Results Provide Boost To Dynavax's Stock

Nov. 30, 2006

By Aaron Lorenzo

Shares in Dynavax Technologies Corp. soared 32 percent Wednesday on positive Phase III data for its hepatitis B vaccine, Heplisav. (BioWorld Today)

View All Articles by Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for May 9, 2025.
100 days of uncertainty
BioWorld
The first 100 days of the Trump administration have been nothing short of chaotic, both in the U.S. and throughout the world. Shining a light through the...
AACR 2025: Induced proximity strategy, beyond degraders
BioWorld
Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
NME Digest: Q1 2025
BioWorld
A quarterly dynamic table featuring new molecular entities (NMEs) revealed for the first time in current literature, at congresses and in company communications...